New York State Common Retirement Fund Has $3.17 Million Stake in Definitive Healthcare Corp. (NASDAQ:DH)

New York State Common Retirement Fund increased its stake in shares of Definitive Healthcare Corp. (NASDAQ:DH) by 3.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 771,792 shares of the company’s stock after acquiring an additional 23,815 shares during the period. New York State Common Retirement Fund owned about 0.67% of Definitive Healthcare worth $3,172,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Massachusetts Financial Services Co. MA raised its holdings in shares of Definitive Healthcare by 36.8% during the third quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock worth $27,058,000 after acquiring an additional 1,626,813 shares during the period. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Definitive Healthcare during the third quarter worth $512,000. Hennion & Walsh Asset Management Inc. grew its position in Definitive Healthcare by 34.1% in the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 50,886 shares of the company’s stock valued at $209,000 after purchasing an additional 12,946 shares in the last quarter. Barclays PLC grew its position in Definitive Healthcare by 318.8% in the third quarter. Barclays PLC now owns 81,916 shares of the company’s stock valued at $366,000 after purchasing an additional 62,354 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its position in Definitive Healthcare by 431.7% in the third quarter. JPMorgan Chase & Co. now owns 222,090 shares of the company’s stock valued at $993,000 after purchasing an additional 180,323 shares in the last quarter. 98.67% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on DH. Barclays reaffirmed an “underweight” rating and issued a $4.00 target price on shares of Definitive Healthcare in a research report on Monday, January 13th. Needham & Company LLC reaffirmed a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Finally, Stephens initiated coverage on shares of Definitive Healthcare in a research report on Friday, December 20th. They issued an “equal weight” rating and a $5.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $5.72.

Definitive Healthcare Price Performance

Shares of Definitive Healthcare stock opened at $3.23 on Friday. Definitive Healthcare Corp. has a twelve month low of $2.58 and a twelve month high of $10.62. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. The company has a 50-day simple moving average of $4.65 and a two-hundred day simple moving average of $4.48. The stock has a market capitalization of $373.14 million, a price-to-earnings ratio of -1.04, a price-to-earnings-growth ratio of 4.06 and a beta of 1.45.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings data on Thursday, February 27th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.04). Definitive Healthcare had a positive return on equity of 1.76% and a negative net margin of 142.38%. The business had revenue of $62.29 million during the quarter, compared to analyst estimates of $60.60 million. Analysts forecast that Definitive Healthcare Corp. will post 0.16 EPS for the current year.

Insider Activity

In other news, insider William Moschella sold 45,000 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the transaction, the insider now directly owns 433,830 shares in the company, valued at approximately $2,039,001. The trade was a 9.40 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 14.84% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.